PrimeKG-Plus: a refreshed and rare-disease-enriched precision medicine knowledge graph
Trinh‐Trung‐Duong NguyeniD, Thuy Nguyen-PhuongiD, Quy‐Hoai NguyeniD, Amna Mumtaz Abbasi, Hanh-Dung Le Phan, Luong Bao-Anh Nguyen, Nhat-Thien Phan, Nurettin Nusret Curabaz, Alexander S. HauseriD, Ziaurrehman TanoliiD, Dinh‐Truong NguyeniD, Albert J. KooistraiD
Abstract
BackgroundDisease-centered knowledge graphs (KGs) support drug repurposing and precision medicine research, yet many remain static after release while primary databases and literature continue to expand. PrimeKG (Precision Medicine Knowledge Graph) is a widely used multimodal KG providing a holistic view of diseases. However, its public release reflects a June 2021 data cutoff, omitting several years of subsequent data growth. This lag is especially consequential for rare diseases, where mechanistic and therapeutic evidence often remains scattered across publications rather than structured resources. FindingWe present PrimeKG-Plus, a refreshed, rare-disease-enriched release of PrimeKG, rebuilt from all twenty original data resources updated to their December 2025 releases and three additional resources: OpenTargets, RepurposeDrugs, and nSIDES. Beyond synchronizing biomedical databases, PrimeKG-Plus captures approximately five years of previously unavailable rare-disease knowledge from the biomedical literature, curated from 637 PubMed abstracts and PubMed Central full-text articles using a language-model-assisted workflow focused on four rare neurological disorders: Canavan disease, Niemann-Pick disease type C, Tay-Sachs disease, and Batten disease. Extracted relations were refined through entity normalization, UMLS synonym mapping, embedding-based similarity ranking, and human expert review. Network topology analysis showed improved indirect drug-disease connectivity across three to six hops and added 447,288 drug-protein-disease paths linking previously unreachable drug-disease pairs. Temporal validation using drug approval records identified 55 molecular entities approved after the original PrimeKG June 2021 cutoff, 46 of which were absent from the original graph. ConclusionPrimeKG-Plus restores the temporal relevance of PrimeKG, providing an updated resource for drug repurposing, rare-disease research, and downstream machine-learning applications.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Building a Knowledge Graph to Enable Precision Medicine
Payal Chandak, Kexin Huang, Marinka Žitnik·Scientific DataPeer-reviewed·Feb 2, 2023
- Every Cure Knowledge Graph: A Unified Biomedical Knowledge Graph for Drug Repurposing
Piotr Kaniewski, Kathleen Carter, … Lee Lancashire·bioRxiv·Aug 31, 2026
- iKraph: a comprehensive, high-quality biomedical knowledge graph for AI-powered, data-driven biomedical research
Yuan Zhang, Xin Sui, … Jinfeng Zhang·Nature Machine IntelligencePeer-reviewed·Mar 17, 2025
- A Literature-Based Knowledge Graph Embedding Method for Identifying Drug Repurposing Opportunities in Rare Diseases
Daniel N. Sosa, Alexander Derry, … Russ Biagio Altman·Pacific Symposium on Biocomputing (PSB)Peer-reviewed·Nov 27, 2019
- IID-KG: An ontology-aligned literature-derived knowledge graph for infectious and immune-mediated diseases
Feng Pan, Yuan Zhang, … Jinfeng Zhang·bioRxiv·May 26, 2026
- Clustering rare diseases within an ontology-enriched knowledge graph
Jaleal S. Sanjak, Jessica Binder, … Ewy A. Mathé·Journal of the American Medical Informatics AssociationPeer-reviewed·Sep 27, 2023